Profile
ABOS VRTX REGN SGEN ALNY ARGX
Company Name Acumen Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $72.69M $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.06K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Mr. Daniel J. O'Connell M.B.A. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABOS VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 1
Quant Rating Sell Sell Buy Neutral Strong Sell Strong Sell
Trading
ABOS VRTX REGN SGEN ALNY ARGX
Last Close $1.23 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $3.54 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $0.9 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -65.25 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 36.67 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
ABOS VRTX REGN SGEN ALNY ARGX
1 Month Return 20.59 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return 6.03 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return -34.92 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return -49.38 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return -28.49 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return -43.06 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1219.96 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
ABOS VRTX REGN SGEN ALNY ARGX
Asset Growth -22.94 % -0.87 % 12.32 %
Gross Profit Growth 100 % 10.25 % 26.81 %
Revenue Growth - 11.66 % 22.97 %
Revenue 3 Year - 45.6 % 147.1 %
Revenue 5 Year -100 % 163.93 % 775.72 %
Revenue 10 Year -100 % 1632.15 % 2487.4 %
EBIT Growth -89.73 % -93.69 % 24.59 %
Net Income Growth -95.39 % -114.8 % 36.82 %
Net Income 3 Yeari Growth Per Share 66.01 % -122.89 % 69.73 %
Net Income 5 Yeari Growth Per Share -770.81 % -145.38 % 73.13 %
Net Income 10 Yeari Growth Per Share -770.81 % 33.84 % 55.09 %
Operating Income Growth -86.49 % -106.08 % 37.31 %
Operating Cash Flow Growth (CFG) -100.2 % -113.93 % -107.98 %
Operating 3 Year CFG -60.43 % -118.65 % 98.8 %
Operating 5 Year CFG -746.03 % -131.3 % 97.44 %
Operating 10 Year CFG -746.03 % 12.43 % 97.08 %
EPS Growth -58.33 % -114.8 % 38.64 %
EPS Diluted Growth -58.33 % -114.97 % 38.64 %
Book Value Per Share -44.97 % -6.59 % 157.17 %
Share Holder 3 Year Equity Growth Per Share -73.01 % 62.6 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 1165.18 % 168.85 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 1165.18 % 1265.7 % -95.83 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 4.27 % 116.42 % -51.69 %
Free Cash Flow Growth -100.14 % -124.1 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ABOS VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -56.85 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -58.24 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -68.38 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 91.82 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -353.37 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.08 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.69 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.69 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 246.42 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.08 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -353.37 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.71 -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM -0.71 -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM -0.71 -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
ABOS VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.1B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.1B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -1.71 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ABOS VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.03B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.06B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.18B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0.2B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.03B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.24B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
ABOS VRTX REGN SGEN ALNY ARGX
Net Income $-0.1B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.09B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.67
AARD Aardvark Therapeutics, Inc. Common Stock 13.95
ABCL AbCellera Biologics Inc. 3.7376
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.91
ABIO ARCA biopharma, Inc. 28.8
ABPWW 0.0292
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.195
ABVC ABVC BioPharma, Inc. 2.175
ABVX Abivax SA American Depositary Shares 7.15
ACAD ACADIA Pharmaceuticals Inc. 22.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6714
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.49
ACIU AC Immune SA 2.095
ACLX Arcellx, Inc. 64.835
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00189 215.485
VTI Vanguard Total Stock Market Index Fund 0 302.04
IBB iShares Biotechnology ETF 0.01258 127.01
IWN iShares Russell 2000 Value ETF 0.00407 157.63
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 45.87
VXF Vanguard Extended Market Index Fund 0 191.48
HDG ProShares Hedge Replication ETF 0.000269689 49.33
UWM ProShares Ultra Russell2000 0.00157102 37.59
VTHR Vanguard Russell 3000 Index Fund 0 270.2
IWC iShares Micro-Cap ETF 0.01304 127.655
URTY ProShares UltraPro Russell2000 0.00125687 39.23
VTWV Vanguard Russell 2000 Value Index Fund 0 138.785
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VTWO Vanguard Russell 2000 Index Fund 0 87.09
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 41.19
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 101.78
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 101.77
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.45
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.44
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.44
BMED BlackRock Future Health ETF 0.03 24.75
DFAU Dimensional US Core Equity Market ETF 0.00048189 41.965
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 21.18
DFAT Dimensional U.S. Targeted Value ETF 0.00000769 53.885
DFAS Dimensional U.S. Small Cap ETF 0.0001142 63.57
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002324 35.55
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 5.268
VTSAX Vanguard Total Stock Market Index Fund 0 145.69
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 6.17
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.65
VITSX Vanguard Total Stock Market Index Fund 0 145.72
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 6.144
IBRN iShares Neuroscience and Healthcare ETF 0.17376 22.2351
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000123949 102.76
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.66
AVSC Avantis U.S. Small Cap Equity ETF 0 51.53
DCOR Dimensional ETF Trust 0.00005219 66.315
VEMPX Vanguard Extended Market Index InstlPlus 0 354.51
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 273.35
RSSL Global X Funds 0 84.895
DXUV Dimensional ETF Trust 0.0000186 53.82
Unlock